Abstract:
The present invention relates to a convergence angle controlling device for a 3-dimensional camera, and more particularly, relates to a device capable of controlling the convergence angle of the 3-dimensional camera module easily by using a horizontal-type linear step motor and a slide bracket. The present invention provides a device for controlling the convergence angle for 3 dimensional camera. which controls the convergence angle easily in using the convergence angle stereo type 3 dimensional camera by the composition of a fixing bracket, a slide bracket and a linear step motor installed between the fixing bracket and the slide bracket so that person can perceive perspective perception fully.
Abstract:
Dispositf d'application oculaire d'un principe actif (1) comprenant une électrode principale (2) comportant une couche isolante, une couche d'adhésif apte à lier la couche isolante à une couche conductrice, caractérisé en ce que l'électrode principale présenteune zone (21, 22) apte à venir en contact avec une paupière d'u oeil.
Abstract:
The present invention provides a method for enhancing the in vivo delivery of chimeric oligonucleotides, containing for example DNA/2'OMeRNA, into cells of a plant, an animal or an human, comprising a step of applying topically to or injecting into a tissue, or tissue adjacent to a tissue, containing said cells, a composition comprising said chimeric oligonucleotide, followed, preceded by, or simultaneous to a step of transferring said chimeric oligonucleotide into said cells by iontophoresis, and relates to a gene therapy method comprising the iontophorically transfer of a chimeric oligonucleotide DNA/2'OMeRNA. The present invention is also directed to particular chimeric oligonucleotides DNA/'OMeRNA capable of inducing or inhibiting the expression of a specific gene involved in eye function by inducing or reverting a mutation in that specific gene, and their use as therapeutic composition for preventing or treating ocular diseases.
Abstract:
The present invention provides a method for enhancing the in vivo delivery of chimeric oligonucleotides, containing for example DNA/2'OMeRNA, into cells of a plant, an animal or an human, comprising a step of applying topically to or injecting into a tissue, or tissue adjacent to a tissue, containing said cells, a composition comprising said chimeric oligonucleotide, followed, preceded by, or simultaneous to a step of transferring said chimeric oligonucleotide into said cells by iontophoresis, and relates to a gene therapy method comprising the iontophorically transfer of a chimeric oligonucleotide DNA/2'OMeRNA. The present invention is also directed to particular chimeric oligonucleotides DNA/'OMeRNA capable of inducing or inhibiting the expression of a specific gene involved in eye function by inducing or reverting a mutation in that specific gene, and their use as therapeutic composition for preventing or treating ocular diseases.